The Parkinson's drug Comtam for obesity and diabetes

DISEASE CATEGORY: Endocrine/metabolic

INDICATION: Obesity; diabetes

In silico and mouse studies identified Comtan entacapone as an FTO inhibitor that could help treat obesity and